top of page
Spero Biopharma
Develops Ladostigil, a drug designed to treat mild cognitive impairment and prevent its progression to Alzheimer's disease, offering early intervention for at-risk patients.
Company Name | Neurotech Category | Market Category | Company Founded Year | Company Location |
|---|---|---|---|---|
Spero Biopharma | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | 2019 | Ramat Hasharon |
Develops Ladostigil, a drug designed to treat mild cognitive impairment and prevent its progression to Alzheimer's disease, offering early intervention for at-risk patients.
bottom of page